Overview


According to FutureWise analysis the market for patient controlled analgesic pumps in 2023 is US$ 0.29 billion, and is expected to reach US$ 0.4 billion by 2031 at a CAGR of 4.1%.

Patient-controlled analgesia (PCA) refers to methods in which a patient can administer their own pain medication. At PCA, doctors and nurses offer computerized pumps that are frequently used by patients who are recovering from surgery. Post-operative care is provided to patients who have undergone surgery. As a result of its pain-control strategy, patients are able to manage their suffering. Patients who have difficulty swallowing medicines may benefit from PCA. Through PCA infusion, morphine, hydromorphine, and fentanyl can be administered. It consists of a computerized pump connected to a medication syringe that administers a small amount of medication continuously. The dose may be predetermined, and patients can simply click a button to receive an additional dose. The device is easy to use for parents and nurses of children under six years old. Patient-controlled analgesia options include oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous. The most common method of administering intravenous opioids on demand is through patient-controlled analgesia. Epidural PCA is administered to women in labor and cancer patients who are unwell. An oral PCA is for a non-prescription or over-the-counter medicine. Transcutaneous delivery uses iontophoretic systems. Demand dosing and continuous infusion are two ways to administer PCA. Demand dosing also involves factors like the demanded dosage, the initial loading dose, the lockout interval, the infusion rate, and the 1-hour and 4-hour restrictions. PCA with proxy is a highly undesirable phenomenon related to PCA (when someone other than the patient presses the button). As a result of technological advancements, chronic illnesses such as pain, diabetes, and cancer are on the rise, advanced safety features, favorable reimbursements, portability, and the ability to infuse multiple medications at the same time, PCA infusion pumps are in high demand. Over the past few decades, chronic diseases like cancer, arthritis, and pain have become more prevalent. Chronic pain will increase the market's overall growth due to the growing number of people suffering from it. Chronic pain will become more common in the future as diabetes and cancer survival rates rise. The use of analgesic pumps has increased in demand because of this chronic pain condition, which necessitates the use of analgesic pumps.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Patient Controlled Analgesic Pumps Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Patient Controlled Analgesic Pumps Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Baxter International Inc.
  • Smiths Group plc
  • B. Braun Melsungen AG
  • Fresenius SECo. KGaA
  • Becton, Dickinson and Company
  • ICU Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Electronic
  • Mechanical

By Application

  • Diabetes
  • Oncology
  • Gastroenterology
  • Hematology
  • Home Care Settings

By End-Use

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Patient Controlled Analgesic Pumps Market By Type, By Application, By End-Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Patient Controlled Analgesic Pumps Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Patient Controlled Analgesic Pumps Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Patient Controlled Analgesic Pumps Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Patient Controlled Analgesic Pumps Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Electronic
        2. Mechanical

  • 8.   Patient Controlled Analgesic Pumps Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diabetes
        2. Oncology
        3. Gastroenterology
        4. Hematology
        5. Home Care Settings

  • 9.   Patient Controlled Analgesic Pumps Market, By End-Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Specialty Clinics
        2. Hospitals
        3. Ambulatory Surgical Centers
        4. Home Care Settings

  • 10.   North America Patient Controlled Analgesic Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Patient Controlled Analgesic Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Patient Controlled Analgesic Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Patient Controlled Analgesic Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Baxter International Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Smiths Group plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. B. Braun Melsungen AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Fresenius SECo. KGaA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Becton, Dickinson and Company
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. ICU Medical
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients